scispace - formally typeset
A

Allison E. Norlander

Researcher at Vanderbilt University

Publications -  32
Citations -  1545

Allison E. Norlander is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Inflammation & Angiotensin II. The author has an hindex of 12, co-authored 23 publications receiving 1036 citations. Previous affiliations of Allison E. Norlander include Vanderbilt University Medical Center.

Papers
More filters
Journal ArticleDOI

The immunology of hypertension.

TL;DR: Recent data suggest that isolevuglandin-modified self-proteins in antigen-presenting cells are immunogenic, promoting cytokine production by the cells in which they are formed and T cell activation.
Journal ArticleDOI

Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans.

TL;DR: Human T cells become activated and invade critical end-organ tissues in response to hypertension in a humanized mouse model and an increase in circulating interleukin-17A producing CD4(+) and CD8(+) T cells that produce interferon-γ in hypertensive compared with normotensive humans is observed.
Journal ArticleDOI

Oligoclonal CD8+ T Cells Play a Critical Role in the Development of Hypertension

TL;DR: Data suggest that in the development of hypertension, an oligoclonal population of CD8+ cells accumulates in the kidney and likely contributes to hypertension by contributing to sodium and volume retention and vascular rarefaction.
Journal ArticleDOI

Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation

TL;DR: Bone marrow transplantation studies demonstrated that loss of LNK in hematopoietic cells is primarily responsible for the observed renal and vascular inflammation and predisposition to hypertension, and results suggest that LNK is a potential therapeutic target for hypertension and its associated kidneys and vascular sequela.